The neutralizing antibody against IGF-1 (human IGF-1 antibody, goat IgG) was from R&D Systems, and the anti-IGF-1 mouse monoclonal antibody was from Santa Cruz Biotechnology
Other failures include using non-bacteriostatic water for reconstitution, storing at incorrect temperatures, and failing to follow aseptic technique
Changes in your digestion "transit time" might mean your thyroid levels fluctuate more than usual
Phase 2 results: the clinical foundation The Phase 2 trial, published in the New England Journal of Medicine in June 2023, remains the most detailed dataset available, and the primary source for dose-specific results at doses below 9mg
Users described chills, feeling persistently cold, hot flashes, and feverlike sensations that did not appear to be linked to illness